Peter Feinberg - 15 Mar 2022 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
Director
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Peter Feinberg
Issuer symbol
IMRX
Transactions as of
15 Mar 2022
Transactions value $
$45,002
Form type
4
Filing time
16 Mar 2022, 17:30:16
Previous filing
21 Sep 2021
Next filing
23 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMRX Class A Common Stock Purchase $45K +6.67K +130.75% $6.75 11.8K 15 Mar 2022 Direct F1
holding IMRX Class A Common Stock 392K 15 Mar 2022 General Partner of PF Associates L.P.
holding IMRX Class A Common Stock 477K 15 Mar 2022 General Partner of PEF LLC.
holding IMRX Class A Common Stock 115K 15 Mar 2022 General Partner of S4K Investments LLC.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades through a broker-dealer at a price of $6.75. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares acquired at such price.